Surgalign Holdings Inc. Stock
Your prediction
Pros and Cons of Surgalign Holdings Inc. in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Surgalign Holdings Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Surgalign Holdings Inc. | - | - | - | - | - | - | - |
| SI-BONE Inc | 0.000% | 1.770% | -3.361% | -1.709% | -31.953% | - | - |
| Lantheus Holdings Inc | -2.150% | 4.059% | -1.660% | -23.633% | 20.105% | -11.674% | - |
| Lemaitre Vascular Inc | 0.510% | 4.255% | 3.158% | 35.172% | 39.007% | - | - |
Comments
Surgalign Holdings, Inc. (NASDAQ: SRGA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.50 price target on the stock.
Show more
Ratings data for SRGA provided by MarketBeat

